riskA recent study in JAMA (Journal of American Medical Association) has raised questions about the safety of one of our most commonly prescribed blood pressured medications, the CALCIUM CHANNEL BLOCKERS.

In a case-control study, the researchers demonstrated at 2.5x greater risk of breast cancer in those women on the medication for 10 years or more.

Although this study is ‘suggestive’ of concern, the method that they used in the study has researchers looking into this questions further and is not definitive enough to warrant a change in our approach.  So, the researchers will be doing more studies, and we will keep our eyes on this, but for now, no change in medication has been recommended.

Despite this, if you remain concerned, please come to the office to discuss this further.

<<<<<<<Calcium Channel Blockers include:  Norvasc (Amlodipine), Calan (Verapamil), Cardizem (Diltiazem), Procardia (Nifedipine)>>>>>>>